Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors.
To determine the effect of different promoters on the expression of an altered dihydrofolate reductase (DHFR) gene conferring methotrexate (MTX) resistance in different cell types, double-copy retroviral vectors were constructed carrying a murine mutant DHFR under the control of five different promoters, i.e., human adenosine deaminase (ADA), simian virus 40 (SV40), thymidine kinase (TK), human beta-actin, and cytomegalovirus (CMV). Their expression was compared in NIH-3T3 cells, three human leukemia cell lines, and mouse bone marrow. The variant DHFR is readily expressed from these various promoters in retroviral vectors at a selectable level. In 3T3 cells, the DHFR constructs containing the SV40 promoter conferred the highest levels of resistance to MTX. In K562 and Raji cells, the construct with the TK promoter produced the highest level of resistance. However granulocyte-macrophage colony-forming unit (CFU-GM) colonies from mouse marrow were more resistant to MTX when infected with vectors containing the SV40 promoter and ADA promoter as compared to the other promoter constructs. These studies show that mouse fibroblast cell lines such as NIH-3T3 do not predict the effectiveness of retroviral-mediated gene transfer for marrow progenitor cells, and that the activity of retroviral vector-encoded promoters vary in an unpredictable manner from cell type to cell type. Possible implications for basic gene transfer studies and clinical applications are discussed.
Li
M
M
Cornell University Graduate School of Medical Sciences, New York, NY.
Hantzopoulos
P A
PA
Banerjee
D
D
Zhao
S C
SC
Schweitzer
B I
BI
Gilboa
E
E
Bertino
J R
JR
D016475:3T3 Cells; D000818:Animals; D015152:Blotting, Northern; D001854:Bone Marrow Cells; D004351:Drug Resistance / Q000235:genetics; D015971:Gene Expression Regulation, Enzymologic; D005822:Genetic Vectors; D006801:Humans; D007938:Leukemia; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D008979:Moloney murine leukemia virus / Q000235:genetics*; D009154:Mutation; D011401:Promoter Regions, Genetic; D013762:Tetrahydrofolate Dehydrogenase / Q000235:genetics* / Q000378:metabolism; D014407:Tumor Cells, Cultured
D013762:Tetrahydrofolate Dehydrogenase; D008727:Methotrexate